iarjalsIARJALSIARJALS2708-5104https://doi.org/10.47310/iarjals.2022.v03i02.013Immunological and genetic evaluation of bladder cancer In Some Iraqi PatientsRawaaNajimAlkhamessiAmranM.AL-ErjanMustafaJawadKadhamThis research aimed to determine the malignant potential of tumors, as well as their response to various therapies, by identifying prospective tumor indicators. As a result, the current investigation was performed to highlight the role of interleukin-1, interleukin-6, interleukin-8, interleukin-17, and TGF in identifying  prognosis of bladder cancer. The immunohistochemistry staining of clinical materials from 30 patients with bladder cancer was done to determine the prognostic value of IL-1, IL-6, IL-8, IL-17, and TGF in connection to clinical outcome. When comparing bladder cancer specimens to controls, the researchers discovered that IL-1, IL-6, IL-8, IL-17, and TGF were significantly overexpressed. After everything was said and done, our data revealed that these cytokines might be a major predictor of the clinical grade and prognosis of bladder cancer. From FFPEblocks, total mRNA was isolated with the use of a specialised kit. The real-time PCR method was used to calculate the levels of HEF1 gene expression.Results were normalized to GAPDA gene as housekeeping gene. The gene expression data were analyzed in relevance to the patient's information obtained. The data was analysed using many statistical methods, which led to the conclusion that the HEF1 gene is expressed 11.219-fold more frequently in malignant bladder tumours than in normal bladder tissue. Genes encoding the transcription factor HEF1 were shown to be overexpressed in tumours of higher grade and later stage, suggesting that they may be a novel bladder tumour marker with prognostic implications that may be included into strategies for managing bladder cancer.